Orthofix Medical (OFIX) Gross Profit (2010 - 2026)

Orthofix Medical (OFIX) has 17 years of Gross Profit data on file, last reported at $139.5 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 14.74% year-over-year to $139.5 million; the trailing twelve-month figure through Mar 2026 stood at $583.9 million (up 8.09% YoY), and the FY2025 full-year result was $566.0 million, up 3.69% from the prior year.
• Gross Profit for Q1 2026 stood at $139.5 million, down from $156.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $156.3 million in Q4 2025 and bottomed at $78.1 million in Q1 2022.
• A 5-year average of $122.1 million and a median of $127.2 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit decreased 7.97% in 2022 and surged 53.21% in 2023, its largest moves.
• Tracing OFIX's Gross Profit over 5 years: stood at $89.2 million in 2022, then jumped by 53.21% to $136.6 million in 2023, then rose by 8.94% to $148.8 million in 2024, then climbed by 5.04% to $156.3 million in 2025, then declined by 10.74% to $139.5 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $139.5 million, $156.3 million, and $148.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison